State of New Jersey Common Pension Fund D
MLTX icon

State of New Jersey Common Pension Fund D’s MoonLake Immunotherapeutics MLTX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$203K Buy
+10,864
New +$180K ﹤0.01% 1528

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State of New Jersey Common Pension Fund D's MLTX Position: Q1 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in MoonLake Immunotherapeutics (MLTX) in Q1 2026: 10,864 shares worth $203K. The stake represents ﹤0.01% of the portfolio and ranks #1528 among its holdings.

147 funds tracked by Wall St. Rank hold MLTX as of Q1 2026.

  • State of New Jersey Common Pension Fund D held 10,864 shares of MoonLake Immunotherapeutics worth $203K as of Q1 2026.
  • MoonLake Immunotherapeutics was a new State of New Jersey Common Pension Fund D position in Q1 2026.
  • MoonLake Immunotherapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q1 2026, its #1528 holding.
  • 147 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q1 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2026, filed 5 May 2026.